UPDATED Apr 17, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AXSM | US$68.21 | -3.9% | -5.5% | US$3.3b | US$121.13 | PS11.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
HDG | ₫26,000.00 | -8.9% | 3.8% | ₫7.9t | ₫32,300.00 | PE12x | E31.4% | 0% | Capital Goods | ||
TGTX | US$13.82 | -6.1% | -36.9% | US$2.0b | US$29.75 | PE157.9x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
ASND | US$142.17 | -6.8% | 71.2% | US$8.1b | US$176.78 | PS28.6x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.28 | -8.0% | 44.6% | US$213.0m | US$8.50 | PS2.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
666 | HK$14.48 | -3.1% | n/a | HK$33.0b | HK$16.93 | PS2.2x | E97.0% | n/a | Capital Goods | ||
AESI | US$21.97 | -7.8% | 21.6% | US$2.4b | US$25.50 | PE22.9x | E61.2% | 3.8% | Energy | ||
ALKT | US$23.84 | 0.2% | 89.8% | US$2.3b | US$28.70 | PS8.8x | E80.1% | n/a | Software | ||
ELF | US$166.26 | -0.6% | 78.7% | US$9.2b | US$206.21 | PE71.3x | E27.2% | n/a | Household | ||
ZVRA | US$4.64 | -5.7% | -23.4% | US$199.6m | US$19.00 | PS7.1x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.38 | -35.0% | -35.6% | US$250.3m | US$26.90 | PS4.8x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.56 | -0.5% | 37.5% | kr421.9m | kr1.80 | PS5.9x | E96.2% | n/a | Tech | ||
AVLL3 | R$3.86 | 0.8% | 28.7% | R$754.0m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
WAYS | kr23.50 | -1.3% | -48.5% | kr189.6m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
GWIND | ₺25.52 | 0.2% | 53.2% | ₺13.8b | ₺39.79 | PE22.1x | E60.9% | 1.8% | Utilities | ||
ATAKP | ₺45.96 | -2.2% | n/a | ₺6.4b | ₺67.66 | PE21.6x | E72.8% | n/a | Food, Beverage & Tobacco | ||
DIRR3 | R$22.29 | -10.8% | 41.7% | R$3.9b | R$28.75 | PE11.6x | E25.1% | 2.1% | Consumer Durables | ||
PRL | CA$21.32 | -1.6% | 215.9% | CA$753.5m | CA$24.37 | PE19.1x | E33.6% | 2.2% | Diversified Financials | ||
ALNY | US$145.32 | -4.7% | -28.2% | US$18.6b | US$220.22 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €9.50 | -2.1% | -2.1% | €59.4m | €11.70 | n/a | E42.0% | n/a | Capital Goods | ||
OSE | €4.88 | 4.8% | -0.4% | €105.1m | €7.15 | PS47.2x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$840.35 | -3.5% | 200.9% | US$2.2t | US$990.33 | PE69.5x | E22.9% | 0.02% | Semiconductors | ||
A211050 | ₩4,900.00 | 5.6% | 126.2% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
5038 | JP¥1,424.00 | 0.6% | -35.9% | JP¥20.6b | n/a | PE34.8x | E24.7% | n/a | Healthcare |